Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression

Journal of Molecular Neuroscience

Volumn 32, Issue 2, 2007, Pages 132-144

  Bisgaard, Christina F ^a   Jayatissa, Magdalena N ^a   Enghild, Jan J ^b   Sanchéz, Connie ^c   Artemychyn, Roman ^c   Wiborg, Ove ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c LUNDBECK RESEARCH USA   (United States)

Author keywords

2D DIGE; Chronic mild stress; Depression; DRP 2; Proteomics; SNAP; Ventral hippocampus

Indexed keywords

BIOLOGICAL MARKER; CHAPERONE; COLLAPSIN RESPONSE MEDIATOR PROTEIN; ESCITALOPRAM; PROTEOME;

AMINO ACID SEQUENCE; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; CYTOSKELETON; DEPRESSION; DISEASE COURSE; DISEASE MARKER; GEL ELECTROPHORESIS; HIPPOCAMPUS; MALE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; RAT; SYMPTOM; TANDEM MASS SPECTROMETRY; TREATMENT PLANNING; TREATMENT RESPONSE;

ANIMAL FEED; ANIMALS; CITALOPRAM; CYTOSKELETAL PROTEINS; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; FEEDING BEHAVIOR; HIPPOCAMPUS; MALE; MEMBRANE PROTEINS; MUSCLE PROTEINS; NERVE TISSUE PROTEINS; NITRIC OXIDE DONORS; PROTEOME; RATS; RATS, WISTAR; S-NITROSO-N-ACETYLPENICILLAMINE; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; SUCROSE;

ANIMALIA; RATTUS;

EID: 34648835409     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-007-0025-4     Document Type: Article

References (59)

1. Alban, A., David, S. O., Bjorkesten, L., Andersson, C., Sloge, E., Lewis, S. et al. (2003). A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics, 3, 36-44.
2. Alfonso, J., Fernández, M. E., Cooper, B., Flugge, G., & Frasch, A. C. (2005). The stress-regulated protein M6a is a key modulator for neurite outgrowth and filopodium/spine formation. PNAS, 102, 17196-17201.
3. Alfonso, J., Frick, L. R., Silberman, D. M., Palumbo, M. L., Genaro, A. M., Frasch, A. C. (2006). Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatment. Biological Psychiatry, 59, 244-251.
4. Babcock, M., Macleod, G. T., Leither, J., & Pallanck, L. (2004). Genetic analysis of soluble N-ethylmaleimide-sensitive factor attachment protein function in Drosophila reveals positive and negative secretory roles. Journal of Neuroscience, 24, 3964-3973.
5. Bannerman, D. M., Rawlins, J. N. P., Mchugh, S. B., Deacon, R. M. J., Yee, B. K., & Bast, T. (2004). Regional dissociations within the hippocampusFmemory and anxiety. Neuroscience and Biobehavioral Reviews, 28, 273-283.
6. Bondolfi, G., Chautems, C., Rochat, B., Bertschy, G., & Baumann, P. (1996). Non response to citalopram in depressive patients: Pharmacokinetic and clinical consequences of a fluvoxamine augmentation. Psychopharmacology, 128, 421-425.
7. Boulenger, J. P., Huusom, A. K. T., Florea, I., Bækdal, T., & Sarchiapone, M. (2006) A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Current Medical Research and Opinion, 22, 1331-1341.
8. Byk, T., Dobransky, T., Cifuentes-Diaz, C., & Sobel, A. (1996). Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product. Journal of Neuroscience, 16, 688-701.
9. Carboni, L., Piubelli, C., Pozzato, C., Astner, H., Arban, R., Righetti, P. G. et al. (2006a). Proteomic analysis of rat hippocampus after repeated psychosocial stress. Neuroscientist, 137, 1237-1246.
10. Carboni, L., Vighini, M., Puibelli, C., Castelletti, L., Milli, A., & Dominici, E. (2006b). Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine putative novel antidepressants: CRF1 and NK1 receptor antagonists. European Neuropsychopharmacology, 16, 688-701.
11. Chen, B., Wang, J.-F., Sun, X., & Young, L. T. (2003). Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells. Biological Psychiatry, 53, 530-537.
12. Dow, A. L., Russell, D. S., & Duman, R. S. (2005). Regulation of Activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: Effects in behavioral models. Journal of Neuroscience, 25, 4908-4916.
13. Einarson, T. R. (2004). Evidence based review of escitalopram in treating major depressive disorder in primary care. International Clinical Psychopharmacology, 19, 305-310.
14. Fukata, Y., Itoh, T. J., Kimura, T., Ménager, C., Nishimura, T., Shiromizu, T. et al. (2002). CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nature Cell Biology, 4, 583-591.
15. Gage, F. H., & Thompson, R. G. (1980). Differential distribution of norepinephrine and serotonin along the dorsal-ventral axis of the hippocampal-formation. Brain Research Bulletin, 5, 771-773.
16. Goshima, Y., Nakamura, F., Strittmatter, P., & Strittmatter, S. M. (1995). Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature, 376, 509-514.
17. Gu, Y., & Ihara, Y. (2000). Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules. Journal of Biological Chemistry, 275, 17917-17920.
18. Hamajima, N., Matsuda, K., Sakata, S., Tamaki, N., & Sasaki, M. (1996). A novel gene family defined by Dihydropyrimidinase and three related proteins with differential tissue distribution. Gene, 180, 157-163.
19. Herman, J. P., Dolgas, C. M., & Carlson, S. L. (1998). Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioral responses to cognitive stressors. Neuroscientist, 86, 449-459.
20. Hock, B. J., & Bunsey, M. D. (1998). Differential effects of dorsal and ventral hippocampal lesions. Journal of Neuroscience, 18, 7027-7032.
21. Inagaki, N., Chihara, K., Arimura, N., Ménager, C., Kawano, Matsuo, N. et al. (2001). CRMP-2 induces axons in cultured hippocampal neurons. Nature Neuroscience, 4, 781-782.
22. Jayatissa, M. N., Bisgaard, C. F., Tingström, A., Papp, M., & Wiborg, O. (2006). Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology, 31, 2395-2404.
23. Johnston-Wilson, N. L., Sims, C. D., Hofman, J.-P., Anderson, L., Shore, A. D., Torrey, E. F. et al. (2000). Disease-specific alterations in frontal cortex brain proteins in Schizophrenia, bipolar disorder, and major depressive disorder. Molecular Psychiatry, 5, 142-149
24. Karp, N. A., & Lilley, K. S. (2005). Maximising sensitivity for detecting changes in protein expression: Experimental design using minimal CyDyes. Proteomics, 5, 3105-3115.
25. Khawaja, X., Xu, J., Liang, J.-J., & Barrett, J. E. (2004). Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. Journal of Neuroscience Research, 75, 451-460.
26. Leonardo, E. D., Richardson-Jones, J. W., Sibille, E., Kottman, A., & Hen, R. (2006). Molecular heterogeneity along the dorsal-ventral axis of the murine hippocampal Ca1 field: A microarray analysis of gene expression. Neuroscience, 137, 177-186.
27. Lilley, K. S., & Friedman, D. B. (2004). All about DIGE: Quantitation technology for differential-display 2D-gel proteomics. Expert Review of Proteomics, 1, 401-409.
28. Lubec, G., Nonaka, M., Krapfenbauer, K., Gratzen, M., Cairns, N., & Fountoulakis, M. (1999). Expression of dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA level and dysregulated at the protein level. Journal of Neural Transmission Supplementum, 57, 161-177.
29. Malberg, J. E., & Blendy, J. A. (2005). Antidepressant action: To the nucleus and beyond. Trends in Pharmacological Sciences, 26, 631-638.
30. Marouga, R., David, S., & Hawkins, E. (2005). The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem, 382, 669-678.
31. Minturn, J. E., Fryer, H. J. L., Geschwind, D. H., & Hockfield, S. (1995). TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. Journal of Neuroscience, 15, 6757-6766.
32. Moore, N., Verdoux, H., & Fantino, B. (2005). Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. International Clinical Psychopharmacology, 20, 131-137.
33. Moreau, J. L., Jenck, F., Martin, J. R., Mortas, P., & Haefely, W. E. (1992). Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmental self-stimulation behaviour in rats. European Neuropsychopharmacology, 2, 43-49.
34. Moreau, J. L., Scherschlicht, R., Jenck, F., & Martin, J. R. (1995). Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment. Behavioural Pharmacology, 6, 682-687.
35. Moser, M. B., & Moser, E. I. (1998). Functional differentiation in the hippocampus. Hippocampus, 8, 608-619.
36. Nadel, L. (1968) Dorsal and ventral hippocampal lesions and behaviour. Physiology & Behavior, 3, 891-900.
37. Newcombe, J., Eriksson, B., Ottervald, J., Yang, Y., & Franzén, B. (2005). Extraction and proteomic analysis of proteins from normal and multiple sclerosis postmortem brain. Journal of Chromatography. B, 815, 191-202.
38. Nishiki, T., Nihonmatsu, I., Tsuhara, Y., Kawasaki, M., Sekiguchi, M., Sato, K. et al. (2001). Distribution of soluble N-ethylmaleimide fusion protein attachment proteins (SNAPs) in the rat nervous system. Neuroscientist, 107, 363-371.
39. Nishimune, A., Isaac, J. T. R., Molnar, E., Noel, J., Nash, S. R., Tagaya, M.et al. (1998). NSF binding to GluR2 regulates synaptic transmission. Neuron, 21, 87-97.
40. Osten, P., Srivastava, S., Inman, G. J., Vilim, F. S., Khatri, L., Lee, L. M. et al. (1998). The AMPA receptor GluR2 C-terminus can mediate a reversible, ATP-dependent interaction with NSF and α-and β-SNAPs. Neuron, 21, 99-110.
41. Papp, M., Moryl, E., & Willner, P. (1996). Pharmacological validation of the chronic mild stress model of depression. European Journal of Pharmacology, 296, 129-136.
42. Papp, M., Willner, P., & Muscat, R. (1991). An animal model of anhedonia: Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berlin), 104, 255-259.
43. Paxinos, G., & Watson, C. (1986). The rat brain in stereotactic coordinates. Sydney, Australia: Academic.
44. Perkins, D. N., Pappin, D. J. C, Creasy, D. M., & Cottrell, J. S. (1999). Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis, 20, 3551-3567.
45. Sánchez, C., Bergqvist, P. B. F, Brennum, L. T., Gupta, S., Hogg, S., Larsen, A. et al. (2003). Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytics activities. Psychopharmacology, 167, 353-362.
46. Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 524-533.
47. Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996). Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Analytical Chemistry, 68, 850-858.
48. Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., Yacoubi, M. E. et al. (2006). Alterations in 5-HT1B receptor function by p11 in depression-like states. Science, 311, 77-80.
49. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R., Rayner, S., Young, J. et al. (2001). Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics, 1, 377-396.
50. Tusher, V. G., Tibshirani, R., & Chu, G. (2001). Significant analysis of microarrays applied to the ionizing radiation response. PNAS, 98, 5116-5121.
51. Ünlu, M., Morgan, M. E., & Minden, J. S. (1997). Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis, 18, 2071-2077.
52. Vaidya, V. A., & Duman, R. S. (2001). Depression: Emerging insights from neurobiology. British Medical Bulletin, 57, 61-79.
53. Voss, T., & Haber, P. (2000). Observations on the reproducibility and matching efficiency of two-dimensional electrophoresis gels: Consequences for comprehensive data analysis. Electrophoresis, 21, 3345-3350.
54. Wang, L.-H., & Strittmatter, S. M. (1996). A family of rat CRMP genes is differentially expressed in the nervous system. Journal of Neuroscience, 16, 6197-6207.
55. Wang, L., Ungermann, C., & Wicker, W. (2000). The docking of primed vacuoles can be reversibly arrested by excess Sec17p (α-SNAP). Journal of Biological Chemistry, 275, 22862-22867.
56. Willner, P. (1997). Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology, 134, 319-329.
57. Willner, P. (2005). Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology, 52, 90-110.
58. Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berlin), 93, 358-364.
59. Wong, M. L., & Lucinio, J. (2004). From monoamines to genomic targets: A paradigm shift for drug discovery in depression. Nature Reviews. Drug Discovery, 3, 136-151.